Current concepts on the mechanisms of dystonia and the beneficial effects of deep brain stimulation.

Stavrinou LC, Boviatsis EJ, Leonardos A, Panourias IG, Sakas DE.

Cent Eur Neurosurg. 2011 Aug;72(3):144-8. doi: 10.1055/s-0031-1271730. Review.

Speech-induced cervical dystonia.

Bouchard M, Furtado S.

Can J Neurol Sci. 2011 Nov;38(6):929-30. No abstract available.

The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias.

Rosales RL, Ng AR, Santos MM, Fernandez HH.

Int J Neurosci. 2011;121 Suppl 1:44-56. doi: 10.3109/00207454.2011.558260.

Dopa-responsive dystonia with a novel initiation codon mutation in the GCH1 gene misdiagnosed as cerebral palsy.

Lee JH, Ki CS, Kim DS, Cho JW, Park KP, Kim S.

J Korean Med Sci. 2011 Sep;26(9):1244-6. doi: 10.3346/jkms.2011.26.9.1244.

Jaw-opening dystonia: Quality of life after botulinum toxin injections.

Charous SJ, Comella CL, Fan W.

Ear Nose Throat J. 2011 Feb;90(2):E9.

Three cases of focal embouchure dystonia: classifications and successful therapy using a dental splint.

Satoh M, Narita M, Tomimoto H.

Eur Neurol. 2011;66(2):85-90. doi: 10.1159/000329578.

Genetics and pharmacological treatment of dystonia.

Barrett MJ, Bressman S.

Int Rev Neurobiol. 2011;98:525-49. doi: 10.1016/B978-0-12-381328-2.00019-5. Review.

Towards a new era for dystonia, a high priority for biomedical research.

Pisani A.

Neurobiol Dis. 2011 May;42(2):125-6. doi: 10.1016/j.nbd.2011.02.001. No abstract available.

Amplitude and timing of somatosensory cortex activity in task-specific focal hand dystonia.

Dolberg R, Hinkley LB, Honma S, Zhu Z, Findlay AM, Byl NN, Nagarajan SS.

Clin Neurophysiol. 2011 Dec;122(12):2441-51. doi: 10.1016/j.clinph.2011.05.020.

SGCE isoform characterization and expression in human brain: implications for myoclonus-dystonia pathogenesis?

Ritz K, van Schaik BD, Jakobs ME, van Kampen AH, Aronica E, Tijssen MA, Baas F.

Eur J Hum Genet. 2011 Apr;19(4):438-44. doi: 10.1038/ejhg.2010.206.

Deep brain stimulation effects in dystonia: time course of electrophysiological changes in early treatment.

Ruge D, Tisch S, Hariz MI, Zrinzo L, Bhatia KP, Quinn NP, Jahanshahi M, Limousin P, Rothwell JC.

Mov Disord. 2011 Aug 15;26(10):1913-21. doi: 10.1002/mds.23731.

Oral pharmacological treatment of X-linked dystonia parkinsonism: successes and failures.

Jamora RD, Diesta CC, Pasco PM, Lee LV.

Int J Neurosci. 2011;121 Suppl 1:18-21. doi: 10.3109/00207454.2010.544433. Review.

Bilateral basal ganglia lesions in a diabetic-uremic patient with dystonia.

Renard D, Castelnovo G, Taieb G, Verd A, Lionnet C, Labauge P.

Acta Neurol Belg. 2011 Jun;111(2):166-7. No abstract available.

Behavioural and pharmacological examinations in a transgenic mouse model of early-onset torsion dystonia.

Lange N, Hamann M, Shashidharan P, Richter A.

Pharmacol Biochem Behav. 2011 Feb;97(4):647-55. doi: 10.1016/j.pbb.2010.11.005.

Thalamic neuronal and EMG activity in psychogenic dystonia compared with organic dystonia.

Kobayashi K, Lang AE, Hallett M, Lenz FA.

Mov Disord. 2011 Jun;26(7):1348-52. doi: 10.1002/mds.23565.